Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

Europe - BIT:ICOS - IT0005455875 - Common Stock

12.26 EUR
+0.16 (+1.32%)
Last: 9/17/2025, 5:35:30 PM
Fundamental Rating

4

Overall ICOS gets a fundamental rating of 4 out of 10. We evaluated ICOS against 13 industry peers in the Personal Care Products industry. ICOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ICOS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ICOS was profitable.
In the past year ICOS had a positive cash flow from operations.
In the past 5 years ICOS has always been profitable.
In the past 5 years ICOS always reported a positive cash flow from operatings.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.71%, ICOS is doing worse than 69.23% of the companies in the same industry.
With a Return On Equity value of 10.16%, ICOS is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
ICOS has a Return On Invested Capital (9.59%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ICOS is below the industry average of 12.42%.
The 3 year average ROIC (9.32%) for ICOS is below the current ROIC(9.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROIC 9.59%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ICOS has a Profit Margin of 4.34%. This is in the lower half of the industry: ICOS underperforms 69.23% of its industry peers.
In the last couple of years the Profit Margin of ICOS has declined.
ICOS has a Operating Margin of 9.31%. This is in the lower half of the industry: ICOS underperforms 69.23% of its industry peers.
In the last couple of years the Operating Margin of ICOS has declined.
The Gross Margin of ICOS (19.84%) is worse than 92.31% of its industry peers.
In the last couple of years the Gross Margin of ICOS has declined.
Industry RankSector Rank
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ICOS is still creating some value.
The number of shares outstanding for ICOS remains at a similar level compared to 1 year ago.
The number of shares outstanding for ICOS has been increased compared to 5 years ago.
Compared to 1 year ago, ICOS has a worse debt to assets ratio.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ICOS has an Altman-Z score of 3.45. This indicates that ICOS is financially healthy and has little risk of bankruptcy at the moment.
ICOS's Altman-Z score of 3.45 is in line compared to the rest of the industry. ICOS outperforms 53.85% of its industry peers.
ICOS has a debt to FCF ratio of 16.66. This is a negative value and a sign of low solvency as ICOS would need 16.66 years to pay back of all of its debts.
With a Debt to FCF ratio value of 16.66, ICOS is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.52 indicates that ICOS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, ICOS is in line with its industry, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Altman-Z 3.45
ROIC/WACC1.42
WACC6.76%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

ICOS has a Current Ratio of 1.67. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ICOS (1.67) is better than 76.92% of its industry peers.
ICOS has a Quick Ratio of 1.03. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
ICOS has a Quick ratio of 1.03. This is in the better half of the industry: ICOS outperforms 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.03
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.80% over the past year.
ICOS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.57% yearly.
ICOS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.02%.
ICOS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.36% yearly.
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%

3.2 Future

The Earnings Per Share is expected to grow by 11.72% on average over the next years. This is quite good.
ICOS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.81% yearly.
EPS Next Y4.9%
EPS Next 2Y11.02%
EPS Next 3Y11.72%
EPS Next 5YN/A
Revenue Next Year2.69%
Revenue Next 2Y4.22%
Revenue Next 3Y4.75%
Revenue Next 5Y1.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.02 indicates a quite expensive valuation of ICOS.
61.54% of the companies in the same industry are cheaper than ICOS, based on the Price/Earnings ratio.
ICOS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.71 indicates a correct valuation of ICOS.
ICOS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ICOS is cheaper than 76.92% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, ICOS is valued a bit cheaper.
Industry RankSector Rank
PE 25.02
Fwd PE 15.71
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICOS is valued a bit cheaper than 69.23% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICOS is valued expensively inside the industry as 84.62% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 75.42
EV/EBITDA 8.27
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.1
PEG (5Y)15.93
EPS Next 2Y11.02%
EPS Next 3Y11.72%

2

5. Dividend

5.1 Amount

ICOS has a Yearly Dividend Yield of 1.72%. Purely for dividend investing, there may be better candidates out there.
ICOS's Dividend Yield is slightly below the industry average, which is at 2.90.
ICOS's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

ICOS pays out 38.09% of its income as dividend. This is a sustainable payout ratio.
DP38.09%
EPS Next 2Y11.02%
EPS Next 3Y11.72%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

INTERCOS SPA

BIT:ICOS (9/17/2025, 5:35:30 PM)

12.26

+0.16 (+1.32%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-04 2025-08-04
Earnings (Next)11-06 2025-11-06
Inst Owners38.09%
Inst Owner ChangeN/A
Ins Owners32.17%
Ins Owner ChangeN/A
Market Cap1.18B
Analysts86.67
Price Target17.39 (41.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP38.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.84%
PT rev (3m)-0.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-8.48%
EPS NY rev (3m)-8.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.64%
Revenue NY rev (3m)-3.57%
Valuation
Industry RankSector Rank
PE 25.02
Fwd PE 15.71
P/S 1.08
P/FCF 75.42
P/OCF 13.2
P/B 2.54
P/tB 4.44
EV/EBITDA 8.27
EPS(TTM)0.49
EY4%
EPS(NY)0.78
Fwd EY6.37%
FCF(TTM)0.16
FCFY1.33%
OCF(TTM)0.93
OCFY7.57%
SpS11.31
BVpS4.83
TBVpS2.76
PEG (NY)5.1
PEG (5Y)15.93
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROCE 14.65%
ROIC 9.59%
ROICexc 11.59%
ROICexgc 17.27%
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
FCFM 1.44%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ROICexc(3y)12.89%
ROICexc(5y)11.65%
ROICexgc(3y)22.3%
ROICexgc(5y)20.57%
ROCE(3y)14.06%
ROCE(5y)12.06%
ROICexcg growth 3Y0.58%
ROICexcg growth 5Y-13.66%
ROICexc growth 3Y4.35%
ROICexc growth 5Y-9.88%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
F-Score7
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Debt/EBITDA 1.6
Cap/Depr 144.42%
Cap/Sales 6.77%
Interest Coverage 11.2
Cash Conversion 58.65%
Profit Quality 33.11%
Current Ratio 1.67
Quick Ratio 1.03
Altman-Z 3.45
F-Score7
WACC6.76%
ROIC/WACC1.42
Cap/Depr(3y)119.92%
Cap/Depr(5y)113.2%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.95%
Profit Quality(3y)77.95%
Profit Quality(5y)89.83%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
EPS Next Y4.9%
EPS Next 2Y11.02%
EPS Next 3Y11.72%
EPS Next 5YN/A
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%
Revenue Next Year2.69%
Revenue Next 2Y4.22%
Revenue Next 3Y4.75%
Revenue Next 5Y1.81%
EBIT growth 1Y16.33%
EBIT growth 3Y15.34%
EBIT growth 5Y2.71%
EBIT Next Year74.29%
EBIT Next 3Y27.67%
EBIT Next 5YN/A
FCF growth 1Y-69.82%
FCF growth 3Y14.23%
FCF growth 5Y-3.11%
OCF growth 1Y-14.11%
OCF growth 3Y17%
OCF growth 5Y3.39%